Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M333Revenue $M61.4Net Margin (%)-151.4Altman Z-Score-43.6
Enterprise Value $M301EPS $-0.6Operating Margin %-140.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.9Pre-tax Margin (%)-153.0Higher ROA y-yN
Price/Book18.510-y EBITDA Growth Rate %-45.2Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %-39.4Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-131.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-420.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M180ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SINGER JACK WEVP, Global Medical Affairs 2015-07-24Sell15,000$1.91-3.14 view
BIANCO LOUIS AEVP, Finance & Administration 2015-07-23Sell10,000$1.91-3.14 view
Plunkett MatthewEVP, Corporate Development 2015-07-06Sell10,000$1.95-5.13 view
SINGER JACK WEVP, Global Medical Affairs 2015-06-26Sell15,000$2.07-10.63 view
BIANCO LOUIS AEVP, Finance & Administration 2015-06-25Sell10,000$2.18-15.14 view
Plunkett MatthewEVP, Corporate Development 2015-06-04Sell10,000$2.06-10.19 view
SINGER JACK WEVP, Global Medical Affairs 2015-05-22Sell15,000$1.746.32 view
BIANCO LOUIS AEVP, Finance & Administration 2015-05-21Sell10,000$1.82.78 view
Plunkett MatthewEVP, Corporate Development 2015-05-04Sell10,000$1.86-0.54 view
SINGER JACK WEVP, Global Medical Affairs 2015-04-24Sell15,000$1.96-5.61 view

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
comment on CTIC Dec 16 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 

More From Other Websites
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jul 30 2015
CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 Jul 28 2015
CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 Jul 28 2015
CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Jul 27 2015
CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President and Chief Commercial Officer Jul 27 2015
CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President and Chief Commercial Officer Jul 27 2015
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 30 2015
3 Biotech Stocks Under $10 to Trade for Breakouts Jun 18 2015
Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In... Jun 15 2015
Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In... Jun 15 2015
Pacritinib Phase 3 Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of... Jun 12 2015
Pacritinib Phase 3 Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of... Jun 12 2015
CTI BIOPHARMA CORP Files SEC form 8-K/A, Other Events Jun 11 2015
CTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jun 10 2015
CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In... Jun 10 2015
CTI BioPharma Amends Loan Agreement Jun 10 2015
CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In... Jun 10 2015
CTI BioPharma Amends Loan Agreement Jun 10 2015
CTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jun 09 2015
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer Jun 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK